AARD

$0.00

(

0.00%

)
Quote details

stock

Aardvark Therapeutics, Inc. Common Stock

NASDAQ | AARD

14.43

USD

$0.00

(

0.00%

)

At Close (As of Dec 12, 2025)

$314.19M

Market Cap

-

P/E Ratio

-2.53

EPS

$19.58

52 Week High

$4.88

52 Week Low

HEALTHCARE

Sector

AARD Chart

Recent Chart
Price Action

AARD Technicals

Tags:

AARD Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$16K
Total Revenue $0
Cost Of Revenue $16K
Costof Goods And Services Sold $16K
Operating Income -$23M
Selling General And Administrative $5.3M
Research And Development $17M
Operating Expenses $23M
Investment Income Net -
Net Interest Income $2.4M
Interest Income $2.4M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $16K
Income Before Tax -$21M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$21M
Comprehensive Income Net Of Tax -
Ebit -$23M
Ebitda -$23M
Net Income -$21M

Revenue & Profitability

AARD Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$16K
Total Revenue $0
Cost Of Revenue $16K
Costof Goods And Services Sold $16K
Operating Income -$23M
Selling General And Administrative $5.3M
Research And Development $17M
Operating Expenses $23M
Investment Income Net -
Net Interest Income $2.4M
Interest Income $2.4M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $16K
Income Before Tax -$21M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$21M
Comprehensive Income Net Of Tax -
Ebit -$23M
Ebitda -$23M
Net Income -$21M

AARD News

AARD Profile

Aardvark Therapeutics, Inc. Common Stock Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Aardvark Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, specializing in the development of innovative small-molecule therapies aimed at activating innate homeostatic pathways to effectively manage metabolic diseases. The company's robust research and development efforts underscore its commitment to addressing significant unmet medical needs, positioning Aardvark for substantial contributions to the biopharmaceutical sector. With a strong pipeline and a focus on rigorous clinical trials, Aardvark is poised to potentially transform the treatment landscape in its targeted therapeutic areas.

LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
OCG
-75.85%
$0.22
YCBD
+90.17%
$1.20
NVDA
-3.26%
$175.02
CGC
+53.98%
$1.74
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.70%
$458.96
AVGO
-11.42%
$359.93
ONDS
-2.99%
$8.75
INTC
-4.30%
$37.81
TLRY
+44.12%
$12.15
ATPC
-25.11%
$0.13
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-29.95%
$0.14
TE
-8.85%
$5.35
ASBP
-9.09%
$0.09
ORCL
-4.46%
$189.97
SOFI
+0.77%
$27.28
VIVK
-1.75%
$0.07
BMNR
-9.17%
$34.86
PFE
+0.19%
$25.85
ZDGE
+14.40%
$2.78
ADAP
-15.14%
$0.05
DNN
-5.43%
$2.61
HPE
-2.73%
$23.87
NFLX
+1.16%
$95.19
F
+0.95%
$13.76
AAL
0.00%
$14.96
PLTD
+2.21%
$6.46
KVUE
+0.05%
$17.33
WBD
+1.66%
$29.98
VHAI
0.00%
$0.00
WULF
-9.47%
$14.33
UGRO
+38.07%
$0.33
MARA
-2.70%
$11.52
SOND
-23.45%
$0.12
PLTR
-2.11%
$183.57
RR
-11.96%
$4.12
BMNU
-18.78%
$8.30
BYND
-7.62%
$1.09
VALE
-2.76%
$12.69
BAC
+1.06%
$55.14
RMBL
+60.50%
$3.21
AAPL
+0.08%
$278.28
LNW
-3.71%
$86.22
ACHR
-3.03%
$8.30
APLT
-45.91%
$0.11
SNAP
-4.31%
$7.31
ADD
-25.47%
$0.05
CLSK
-5.33%
$14.03
BITF
-6.80%
$2.74
IVP
-12.42%
$0.04
AMD
-4.80%
$210.78
GOOGL
-1.00%
$309.29
AMZN
-1.77%
$226.19
IREN
-8.67%
$40.13
IRBT
-13.60%
$4.32
CRWV
-10.05%
$78.59
BTG
-1.70%
$4.60
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
T
+1.15%
$24.58
CVE
+1.74%
$18.03
RIG
-3.50%
$4.13
RKLB
-3.21%
$61.49
QBTS
-6.71%
$26.10
NIO
-1.94%
$5.03
HOOD
-3.14%
$119.50
CIFR
-9.69%
$17.05
RGTI
-3.86%
$25.84
TWOH
-7.69%
$0.00
GRAB
-0.57%
$5.15
CAN
-9.05%
$0.84
SMR
-13.57%
$18.34
BBD
+1.17%
$3.45
CMG
+3.64%
$36.14
MTSR
-0.35%
$70.50
SOUN
-3.15%
$11.65
CHR
0.00%
$0.04
ABEV
+2.00%
$2.55
MU
-6.70%
$241.14
JBLU
+1.02%
$4.94
HL
-2.79%
$18.81
KIND
-14.44%
$2.37
NXDR
-14.44%
$2.37
IBRX
+7.76%
$2.36
NOK
-1.41%
$6.27
AG
-5.17%
$15.94
APLD
-9.42%
$27.86
BTBT
-8.53%
$2.25
CDE
-1.31%
$17.25
LPTX
+368.57%
$2.05
PAVS
+19.13%
$0.04
OCG
-75.85%
$0.22
YCBD
+90.17%
$1.20
NVDA
-3.26%
$175.02
CGC
+53.98%
$1.74
YGMZ
-61.42%
$0.02
WOK
-35.71%
$0.10
PLUG
-1.69%
$2.32
ASST
-6.35%
$0.86
RIVN
+12.11%
$18.42
TSLA
+2.70%
$458.96
AVGO
-11.42%
$359.93
ONDS
-2.99%
$8.75
INTC
-4.30%
$37.81
TLRY
+44.12%
$12.15
ATPC
-25.11%
$0.13
IQ
-4.41%
$1.95
AXDX
-61.36%
$0.03
TNYA
-37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN
+19.53%
$0.94
KAVL
-29.95%
$0.14
TE
-8.85%
$5.35
ASBP
-9.09%
$0.09
ORCL
-4.46%
$189.97
SOFI
+0.77%
$27.28
VIVK
-1.75%
$0.07
BMNR
-9.17%
$34.86
PFE
+0.19%
$25.85
ZDGE
+14.40%
$2.78
ADAP
-15.14%
$0.05
DNN
-5.43%
$2.61
HPE
-2.73%
$23.87
NFLX
+1.16%
$95.19
F
+0.95%
$13.76
AAL
0.00%
$14.96
PLTD
+2.21%
$6.46
KVUE
+0.05%
$17.33
WBD
+1.66%
$29.98
VHAI
0.00%
$0.00
WULF
-9.47%
$14.33
UGRO
+38.07%
$0.33
MARA
-2.70%
$11.52
SOND
-23.45%
$0.12
PLTR
-2.11%
$183.57
RR
-11.96%
$4.12
BMNU
-18.78%
$8.30
BYND
-7.62%
$1.09
VALE
-2.76%
$12.69
BAC
+1.06%
$55.14
RMBL
+60.50%
$3.21
AAPL
+0.08%
$278.28
LNW
-3.71%
$86.22
ACHR
-3.03%
$8.30
APLT
-45.91%
$0.11
SNAP
-4.31%
$7.31
ADD
-25.47%
$0.05
CLSK
-5.33%
$14.03
BITF
-6.80%
$2.74
IVP
-12.42%
$0.04
AMD
-4.80%
$210.78
GOOGL
-1.00%
$309.29
AMZN
-1.77%
$226.19
IREN
-8.67%
$40.13
IRBT
-13.60%
$4.32
CRWV
-10.05%
$78.59
BTG
-1.70%
$4.60
RZLT
+28.57%
$1.80
SRM
+53.27%
$10.30
T
+1.15%
$24.58
CVE
+1.74%
$18.03
RIG
-3.50%
$4.13
RKLB
-3.21%
$61.49
QBTS
-6.71%
$26.10
NIO
-1.94%
$5.03
HOOD
-3.14%
$119.50
CIFR
-9.69%
$17.05
RGTI
-3.86%
$25.84
TWOH
-7.69%
$0.00
GRAB
-0.57%
$5.15
CAN
-9.05%
$0.84
SMR
-13.57%
$18.34
BBD
+1.17%
$3.45
CMG
+3.64%
$36.14
MTSR
-0.35%
$70.50
SOUN
-3.15%
$11.65
CHR
0.00%
$0.04
ABEV
+2.00%
$2.55
MU
-6.70%
$241.14
JBLU
+1.02%
$4.94
HL
-2.79%
$18.81
KIND
-14.44%
$2.37
NXDR
-14.44%
$2.37
IBRX
+7.76%
$2.36
NOK
-1.41%
$6.27
AG
-5.17%
$15.94
APLD
-9.42%
$27.86
BTBT
-8.53%
$2.25
CDE
-1.31%
$17.25

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.